3543-72-4: Bendamustine Nitro Ethyl Ester Impurity

It is a Bendamustine intermediate. Bendamustine is employed to treat bound sorts of cancer (such as cancer, and chronic leukemia – CLL). Bendamustine belongs to a category of cancer therapy medicine called alkylating agents. It works by killing cancer cells or fastness their growth.

Additional information on CAS 3543-72-4

Catalogue No.

VE007302

CAS No.

3543-72-4

Molecular Formula

C14H17N3O4

Molecular Weight

291.3 g/mol

Parent drug

Bendamustine

IUPAC Name

ethyl 4-(1-methyl-5-nitro-1H-benzo[d]imidazol-2-yl)butanoate

Synonyms

N/A

References

“Sci-Hub, Bendamustine, 10.2165/00003495-200161050-00009.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.2165/00003495-200161050-00009.

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

3543-72-4: Bendamustine Nitro Ethyl Ester Impurity

3543-72-4: Bendamustine Nitro Ethyl Ester Impurity
Catalogue No.

VE007302

CAS No.

3543-72-4

Molecular Formula

C14H17N3O4

Molecular Weight

291.3 g/mol

Parent drug

Bendamustine

IUPAC Name

ethyl 4-(1-methyl-5-nitro-1H-benzo[d]imidazol-2-yl)butanoate

Synonyms

N/A

Smile
References

“Sci-Hub, Bendamustine, 10.2165/00003495-200161050-00009.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.2165/00003495-200161050-00009.

Status

In-stock

ListName

Bendamustine Nitro Ethyl Ester Impurity

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden